In addition, we explored the mechanism by which SchA exerts its anti-inflammatory effects on COPD model mice and found that SchA may modulate the Nrf2 signaling pathway and NLRP3 inflammasome activation, which may be significant in the treatment of COPD. Here, NLRP3 is linked to chronic obstructive pulmonary disease.